German (DAX) Medical Equipment Industry Analysis

Industry Valuation and Performance

Has the German Medical Equipment Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sat, 01 Aug 2026	€51.2b	€33.6b	€2.5b	18.4x	20.2x	1.5x
Mon, 29 Jun 2026	€47.5b	€33.5b	€2.5b	18.2x	18.8x	1.4x
Wed, 27 May 2026	€48.0b	€33.5b	€2.5b	18.4x	19x	1.4x
Fri, 24 Apr 2026	€50.2b	€33.7b	€2.6b	16.8x	19.5x	1.5x
Sun, 22 Mar 2026	€49.2b	€33.6b	€2.6b	15.9x	19.2x	1.5x
Tue, 17 Feb 2026	€55.2b	€33.6b	€2.5b	17x	21.9x	1.6x
Thu, 15 Jan 2026	€64.2b	€33.7b	€2.6b	21.7x	25x	1.9x
Sat, 13 Dec 2025	€60.2b	€33.7b	€2.6b	20.1x	23.3x	1.8x
Mon, 10 Nov 2025	€59.8b	€33.7b	€2.6b	15.4x	22.8x	1.8x
Wed, 08 Oct 2025	€61.8b	€32.0b	€2.6b	21.4x	24x	1.9x
Fri, 05 Sep 2025	€60.2b	€32.0b	€2.6b	17.1x	23.5x	1.9x
Sun, 03 Aug 2025	€60.3b	€32.0b	€2.6b	22.1x	23.3x	1.9x
Tue, 01 Jul 2025	€61.5b	€31.7b	€2.5b	22.1x	24.4x	1.9x
Thu, 29 May 2025	€61.5b	€31.7b	€2.5b	19.4x	24.5x	1.9x
Sat, 26 Apr 2025	€61.2b	€31.2b	€2.4b	26.7x	25.4x	2x
Mon, 24 Mar 2025	€67.2b	€31.1b	€2.4b	29.2x	27.9x	2.2x
Wed, 19 Feb 2025	€72.6b	€31.1b	€2.4b	30.9x	30.7x	2.3x
Fri, 17 Jan 2025	€64.5b	€30.8b	€2.3b	26.5x	27.6x	2.1x
Sun, 15 Dec 2024	€67.5b	€30.8b	€2.3b	26.5x	28.9x	2.2x
Tue, 12 Nov 2024	€66.4b	€30.8b	€2.4b	26.2x	28.1x	2.2x
Thu, 10 Oct 2024	€66.7b	€30.5b	€2.3b	26.2x	29.1x	2.2x
Sat, 07 Sep 2024	€64.7b	€30.5b	€2.3b	25.4x	28.2x	2.1x
Mon, 05 Aug 2024	€63.2b	€30.5b	€2.3b	25x	27.3x	2.1x
Wed, 03 Jul 2024	€69.3b	€30.2b	€2.3b	26x	30.5x	2.3x
Fri, 31 May 2024	€71.0b	€30.2b	€2.3b	28.1x	31.3x	2.3x
Sun, 28 Apr 2024	€71.1b	€30.2b	€2.0b	25.7x	36.3x	2.4x
Tue, 26 Mar 2024	€75.4b	€30.2b	€2.0b	27.2x	38.3x	2.5x
Thu, 22 Feb 2024	€72.6b	€30.2b	€1.9b	32.9x	37.3x	2.4x
Sat, 20 Jan 2024	€70.2b	€30.1b	€1.9b	31.1x	36.3x	2.3x
Mon, 18 Dec 2023	€71.3b	€30.1b	€1.9b	30.5x	36.9x	2.4x
Wed, 15 Nov 2023	€66.4b	€30.0b	€1.9b	30.1x	34.1x	2.2x
Fri, 13 Oct 2023	€68.6b	€29.9b	€2.0b	27x	34.3x	2.3x
Sun, 10 Sep 2023	€60.5b	€29.9b	€2.0b	27.6x	30.3x	2x
Tue, 08 Aug 2023	€66.6b	€29.8b	€2.0b	28.5x	33.6x	2.2x

Current Industry PE

Investors are pessimistic on the German Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 20.2x which is lower than its 3-year average PE of 27.7x.

The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.5x.

Past Earnings Growth

The earnings for companies in the Medical Equipment industry have grown 8.6% per year over the last three years.
Revenues for these companies have grown 4.0% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?


DE Market	1.75%
Healthcare	3.21%
Medical Equipment	5.15%
Medical Equipment	5.23%
Medical Supplies	0.98%

Industry PE

Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 27.9x.

Analysts are expecting annual earnings growth of 12.8%, which is lower than the prior year's growth of 21.5% per year.

Investors are most pessimistic about the Medical Supplies industry, which is trading below its 3-year average of 25.3x.

Forecasted Growth

Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 13% over the next 5 years.
However this is lower than its past earnings growth rate of 22% per year.

In contrast, the Medical Supplies industry is expected to see its earnings decline by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
SHL Siemens Healthineers	€36.86	5.1% +€2.0b	-20.6%	PE19.6x
AFX Carl Zeiss Meditec	€30.50	9.7% +€236.3m	-34.1%	PE28.1x
OBCK Ottobock SE KGaA	€56.10	1.3% +€44.8m	n/a	PE39.1x
EUZ Eckert & Ziegler	€13.61	2.3% +€19.4m	-33.9%	PE17.2x
PHH2 Paul Hartmann	€203.00	1.0% +€7.1m	-15.4%	PE11.8x

BiBBInstruments AB Receives Intention To Grant For Fourth And Fifth EndoDrill Patent In Europe And Is Granted Second Patent In India

BiBBInstruments AB announced that the Company has received two Intentions to Grant from the European Patent Office (EPO) as well as a patent grant from the Indian Patent Office (IPO). The European patents will be granted following the completion of certain formalities, after which they will be valid until 2040 and 2041, respectively. The patent in India is valid until 2041. The protection is based on three international EndoDrill patent families with granted patents in Europe, the United States, Japan, India and China. The two Intention to Grant in Europe relate to patent applications No. 20719144.6 and 21716219.7 respectively. These patents belong to BiBB's second and third EndoDrill patent families and provide additional protection for the Company's powered biopsy technology in Europe. Previously, BiBB has been granted three patents in Europe that are valid until 2038 and 2039, and the new patents will extend the protection until 2040 and 2041, respectively. The second granted patent in India (No. 596371) belongs to BiBB's third EndoDrill patent family and provides robust protection for the Company's powered biopsy technology in India. The first granted patent is valid until 2039, while this patent will be valid until 2041. EndoDrill is designed to obtain core needle biopsy (CNB) samples with high diagnostic accuracy and aims to improve the diagnosis of cancer in, among other organs, the stomach, pancreas, liver, lungs and urinary bladder. The product portfolio addresses the global market for ultrasound-guided endoscopic biopsy instruments (EUS/EBUS), one of the most advanced and fastest-growing segments within modern endoscopy. BiBB received FDA 510(k) clearance for EndoDrill GI in 2023 and CE marking under the MDR for EndoDrill GI, EndoDrill EBUS and EndoDrill URO in 2024. EndoDrill is therefore the first powered biopsy system to be market-cleared in the United States and CE-marked in Europe. The U.S. launch of EndoDrill GI commenced during the second half of 2025 together with TaeWoong Medical USA. The European launch begins in 2026 with the Company's partner, Palex Medical Spain. The EndoDrill system consists of sterile single-use instruments and a proprietary drive system.

German (DAX) Medical Equipment Industry Analysis

Industry Valuation and Performance

Industry Trends

Top Stock Gainers and Losers

Latest News

Siemens Healthineers Announces Appointment of João Seabra as President and Head of the Americas, Effective October 1, 2026

BiBBInstruments AB Receives Intention To Grant For Fourth And Fifth EndoDrill Patent In Europe And Is Granted Second Patent In India

Pentixapharm Holding AG has completed a Follow-on Equity Offering in the amount of €20.387392 million.

AFX: Reset Expectations And New Leadership Will Support Future Upside

Redsense Medical AB (publ) to Report Q2, 2026 Results on Aug 19, 2026

Upcoming dividend of €0.10 per share

NanoRepro AG to Report Fiscal Year 2025 Results on Jul 30, 2026

Investor sentiment improves as stock rises 15%

New minor risk - Dividend sustainability

SBS: Future Upside Will Rely On Reset Margins And Lower P/E

aap Implantate AG, Annual General Meeting, Jun 23, 2026

There May Be Reason For Hope In Paul Hartmann's (FRA:PHH2) Disappointing Earnings

elexxion AG, Annual General Meeting, Nov 12, 2025

New major risk - Financial data availability